A detailed history of Goldman Sachs Group Inc transactions in Lifevantage Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 44,571 shares of LFVN stock, worth $397,127. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,571
Previous 44,518 0.12%
Holding current value
$397,127
Previous $649,000 10.32%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$11.18 - $16.05 $592 - $850
53 Added 0.12%
44,571 $582,000
Q1 2025

May 09, 2025

BUY
$14.42 - $25.62 $126,348 - $224,482
8,762 Added 24.5%
44,518 $649,000
Q4 2024

Feb 11, 2025

BUY
$11.34 - $17.85 $405,473 - $638,244
35,756 New
35,756 $627,000

Others Institutions Holding LFVN

About Lifevantage Corp


  • Ticker LFVN
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Shares Outstandng 12,560,000
  • Market Cap $112M
  • Description
  • LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...
More about LFVN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.